Graham Capital Management, L.P. Xeris Biopharma Holdings, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 133,668 shares of XERS stock, worth $679,033. This represents 0.02% of its overall portfolio holdings.
Number of Shares
133,668
Previous 70,662
89.17%
Holding current value
$679,033
Previous $239,000
206.69%
% of portfolio
0.02%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.6MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$52.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$41.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$17.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.9 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $691M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...